Medications

ACE inhibitor/ARB use not tied to COVID-19 test positivity

(HealthDay)—Angiotensin-converting enzyme inhibitor (ACEI) and/or angiotensin receptor blocker (ARB) use is not associated with COVID-19 test positivity, according to a study published online May 5 in JAMA Cardiology.

Diseases, Conditions, Syndromes

Talking receptors may affect relaxin at work

Fibrosis, the damaging build-up of hardened or scarred tissue in the body, is a hallmark of various diseases and can lead to the dysfunction and failure of organs such as the heart and kidney. Fibrosis-related diseases in ...

Diseases, Conditions, Syndromes

How comorbidities increase risks for COVID patients

Comorbidities such as heart disease, respiratory disease, renal disease and cancer lead to an increased risk of death from COVID-19 according to new research from the University of East Anglia (UEA) and the Norfolk and Norwich ...

Diseases, Conditions, Syndromes

Generic heart disease medications offer promise for Ebola treatment

Generic medications used frequently in the management of heart disease patients also have the potential to bolster the immune systems of patients with Ebola virus and some other life-threatening illnesses, researchers report ...

Cardiology

New treatment for Marfan syndrome shows promise

An investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, new research shows. The findings ...

Diseases, Conditions, Syndromes

Study proves safety of hypertension drugs in COVID-19 era

Patients with high blood pressure have worse COVID-19 outcomes, and this led to speculation that some anti-hypertensive medications may pose increased risks to patients dealing with hypertension.

page 6 from 8